SPRY

ARS Pharmaceuticals, Inc (SPRY)

US
$ 13.77-5.94%

Price Chart

Key Statistics

Market Cap
$ 1.74B
P/E Ratio
0.00
Revenue (TTM)
$ 97.12M
Volume
968.62K
52W High
$ 18.90
52W Low
$ 8.91
Dividend Yield
0.00%
Beta
0.87

Technicals

50-Day MA
15.0923
200-Day MA
13.6749
52 Week High
18.9
52 Week Low
8.9055

About SPRY

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Employees
155
Headquarters
San Diego, CA
CEO
Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg